Follow Me on Twitter

Friday, August 16, 2019

$CBDY Investors Have a Rare Opportunity to Own an Investment Which is Impacting The Legal Cannabis Industry


$CBDY Investors Have a Rare Opportunity to Own an Investment Which is Impacting The Legal Cannabis Industry
Fully reporting public company: CBDY (Target Group, Inc.) in a Leading Position to Serve the New Legal Cannabis Marketplace

Target Group, Inc. (OTC: CBDY) based in Ontario, Canada is a progressive, diversified, and vertically integrated cannabis investment company strategically aligned with a key subsidiary and industry partners to optimize a full range of legal cannabis business opportunities currently evolving worldwide. CBDY already has impressive facilities and is still expanding operations to build an international network of manufacturing, distribution, production, and sales operations. This ideally structured agricultural growth and consulting company is creating an iconic brand portfolio, leveraging product diversification, innovation, and operational expertise to solidify long-term growth and stability.





With major legislative changes that have recently occurred in Canada, the US and beyond, legalizing multipronged cannabis related product sale and use applications, we have seen swarms of new businesses emerging to seize upon the high revenue generation opportunities just created for them.  The prolific spread of new CBD infused product marketers is the most obvious example, in addition to traditional medical and recreational products.  All of these business niches are now growing at a rapid rate that is virtually unparalleled in recent history.     
Target Group, with the very appropriate trading symbol of CBDY is positioned with the assets, professional management experience and specific industry expertise to address the needs of the new cannabis related businesses emerging today. CBDY provides consulting services to help clients reach the clearest path to the success of their business plans. Target Group is also developing its own high capacity cannabis agricultural growth facilities for the many new CBD and related product marketing companies with dramatically increasing supply demands.
In May of 2019 CBDY’s wholly owned subsidiary, Canary Rx Inc. completed the build-out of a new 44,000 sq. ft. cannabis production facility in Norfolk County, Ontario. The state-of-the-art facility was designed by cannabis growers, for cannabis growers and engineered to meet Health Canada's rigorous quality and security standards. The production area is equipped with sophisticated environmental control technology, custom-built to regulate eight 2,200 sq. ft. flower rooms as well as vegetative, breeding, testing, and curing spaces. 
Shortly after the opening of this facility Canary Rx submitted a Site Evidence Package to Health Canada pursuant to its Cultivation, Processing and Sales License application under the Canadian Cannabis Act. This package demonstrates to Health Canada that Canary's facility is complete, compliant and operationally ready.  Submission marks the final step in Canary's bid to obtain a license to cultivate cannabis at the company's production facility.
In June CBDY impressed the investment community again with the announcement that Canary Rx had entered a strategic alliance with CANABC Services Ltd. to provide vital consulting and distribution services to Micro License applicants.
CANABC is a medical and regulatory consulting firm that has assisted more than 8,000 patients to obtain medical cannabis documents.  CANABC will now offer a comprehensive suite of consulting services to assist Micro Cultivation, Processing and Nursery applicants to obtain a license under the Cannabis Act.
Micro License applicants often referred to as 'craft' growers, face many obstacles as they attempt to prepare a compliant facility and processes, obtain a license from Health Canada, and meet the ongoing regulatory compliance requirements. In contrast to traditional consulting firms, CANABC will provide fully-customized Standard Operating Procedures (SOPs) and Good Production Practices (GPPs) prepared by a Quality Assurance Specialist, and assist Micro's with ongoing compliance once licensed. Additionally, Canary will offer distribution services to Micro Cultivators that are restricted to selling cannabis to Licensed Producers under the current regulations.
In summary, Target Group (CBDY) is a rare investment opportunity at a pivotal moment where an entire industry is just coming into play.  Learn more via the company websites:
Target Group, Inc.  www.targetgroupinc.ca
Canary Rx Inc. www.canaryrx.com
CANABC Services www.canabc.com

No comments:

Post a Comment